Michael M. Hoffmann

7.8k total citations
143 papers, 4.5k citations indexed

About

Michael M. Hoffmann is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Michael M. Hoffmann has authored 143 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Surgery, 53 papers in Endocrinology, Diabetes and Metabolism and 32 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Michael M. Hoffmann's work include Lipoproteins and Cardiovascular Health (40 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (35 papers) and Adipokines, Inflammation, and Metabolic Diseases (13 papers). Michael M. Hoffmann is often cited by papers focused on Lipoproteins and Cardiovascular Health (40 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (35 papers) and Adipokines, Inflammation, and Metabolic Diseases (13 papers). Michael M. Hoffmann collaborates with scholars based in Germany, Austria and United States. Michael M. Hoffmann's co-authors include Winfried März, Bernhard R. Winkelmann, Heinrich Wieland, Karl Winkler, Bernhard O. Boehm, Johanna Weiß, Hubert Scharnagl, Walter E. Haefeli, Markus Nauck and I. Friedrich and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Michael M. Hoffmann

141 papers receiving 4.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael M. Hoffmann Germany	39	1.4k	1.1k	888	715	605	143	4.5k
Shizuya Yamashita Japan	35	1.4k 1.0×	1.4k 1.3×	1.2k 1.3×	633 0.9×	510 0.8×	97	3.6k
Daniela Foti Italy	39	752 0.5×	1.8k 1.7×	1.1k 1.3×	709 1.0×	796 1.3×	145	4.9k
Jian‐Jun Li China	40	2.5k 1.7×	834 0.8×	887 1.0×	672 0.9×	740 1.2×	229	5.5k
Heinrich Wieland Germany	37	1.9k 1.4×	1.0k 1.0×	1.6k 1.8×	533 0.7×	675 1.1×	144	5.1k
Francesco Paolo D’Armiento Italy	35	1.4k 1.0×	949 0.9×	371 0.4×	527 0.7×	355 0.6×	128	4.8k
Junichi Masuda Japan	38	910 0.6×	1.1k 1.0×	437 0.5×	1.0k 1.4×	345 0.6×	161	4.8k
Francesco Paolo Mancini Italy	32	803 0.6×	1.5k 1.4×	404 0.5×	460 0.6×	449 0.7×	86	3.9k
Lisa R. Tannock United States	32	1.1k 0.8×	1.3k 1.2×	841 0.9×	522 0.7×	371 0.6×	81	3.4k
Jan‐Luuk Hillebrands Netherlands	39	1.2k 0.8×	1.5k 1.4×	644 0.7×	401 0.6×	248 0.4×	173	6.1k
Masanobu Kawakami Japan	41	1.1k 0.8×	1.4k 1.3×	765 0.9×	837 1.2×	292 0.5×	193	5.2k

Countries citing papers authored by Michael M. Hoffmann

Since Specialization

Citations

This map shows the geographic impact of Michael M. Hoffmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael M. Hoffmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael M. Hoffmann more than expected).

Fields of papers citing papers by Michael M. Hoffmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael M. Hoffmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael M. Hoffmann. The network helps show where Michael M. Hoffmann may publish in the future.

Co-authorship network of co-authors of Michael M. Hoffmann

This figure shows the co-authorship network connecting the top 25 collaborators of Michael M. Hoffmann. A scholar is included among the top collaborators of Michael M. Hoffmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael M. Hoffmann. Michael M. Hoffmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Silbernagel, Günther, Yan Chen, Marcus E. Kleber, et al.. (2023). Inverse association between apolipoprotein C-II and cardiovascular mortality: role of lipoprotein lipase activity modulation. European Heart Journal. 44(25). 2335–2345. 11 indexed citations

Hoffmann, Michael M., Sarah K Gebauer, Matthias Nüchter, et al.. (2017). Endokrine Modulatoren Endocrine disruptors. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 211. 0. 3 indexed citations

Koentges, Christoph, María Cecilia Cimolai, Katharina Pfeil, et al.. (2017). P1567Mitochondrial calpains mediate SIRT3-dependent cardiac dysfunction in LPS-induced endotoxemia. European Heart Journal. 38(suppl_1). 1 indexed citations

Braun, Martin, Christoph Koentges, Katharina Pfeil, et al.. (2015). Myocardial Mitochondrial and Contractile Function Are Preserved in Mice Lacking Adiponectin. PLoS ONE. 10(3). e0119416–e0119416. 11 indexed citations

Malinoc, Angelica, Maren Sullivan, Thorsten Wiech, et al.. (2012). Biallelic inactivation of the SDHC gene in renal carcinoma associated with paraganglioma syndrome type 3. Endocrine Related Cancer. 19(3). 283–290. 47 indexed citations

Neß, Thomas, Michael M. Hoffmann, Daniel Boehringer, Sonja Heinzelmann, & Enken Gundlach. (2012). Soluble Interleukin 2 Receptor, Angiotensin Converting Enzyme, And Neopterin in Screening Ocular Sarcoidosis And Monitoring Disease Activity. Investigative Ophthalmology & Visual Science. 53(14). 5481–5481. 2 indexed citations

Dai, Fangping, Florian Leese, W. Schempp, et al.. (2011). Diversification and Molecular Evolution of ATOH8, a Gene Encoding a bHLH Transcription Factor. PLoS ONE. 6(8). e23005–e23005. 22 indexed citations

Arnold, H., et al.. (2011). High levels of brain-type creatine kinase activity in human platelets and leukocytes: A genetic anomaly with autosomal dominant inheritance. Blood Cells Molecules and Diseases. 48(1). 62–67. 5 indexed citations

Winkler, Karl, et al.. (2011). Lipoprotein‐associated phospholipase A2 and outcome in patients with type 2 diabetes on haemodialysis. European Journal of Clinical Investigation. 42(7). 693–701. 9 indexed citations

10.

Costet, Philippe, Michael M. Hoffmann, Bertrand Cariou, et al.. (2010). Plasma PCSK9 is increased by Fenofibrate and Atorvastatin in a non-additive fashion in diabetic patients. Atherosclerosis. 212(1). 246–251. 78 indexed citations

11.

Silbernagel, Günther, Günter Fauler, Michael M. Hoffmann, et al.. (2010). The associations of cholesterol metabolism and plasma plant sterols with all-cause and cardiovascular mortality. Journal of Lipid Research. 51(8). 2384–2393. 74 indexed citations

12.

Silbernagel, Günther, Günter Fauler, Wilfried Renner, et al.. (2008). The relationships of cholesterol metabolism and plasma plant sterols with the severity of coronary artery disease. Journal of Lipid Research. 50(2). 334–341. 70 indexed citations

13.

Rothenbacher, Dietrich, Hermann Brenner, Thomas Mertens, et al.. (2005). Prognostic value of interleukin-1 receptor antagonist gene polymorphism and cytomegalovirus seroprevalence in patients with coronary artery disease. BMC Cardiovascular Disorders. 5(1). 10–10. 5 indexed citations

14.

Weiß, Johanna, Walter E. Haefeli, Christiane Gasse, et al.. (2003). Lack of Evidence for Association of High Altitude Pulmonary Edema and Polymorphisms of the NO Pathway. High Altitude Medicine & Biology. 4(3). 355–366. 33 indexed citations

15.

Ljungberg, M. Cecilia, Ayodeji A. Asuni, Rejith Dayanandan, et al.. (2003). Apolipoprotein E (apoE) uptake and distribution in mammalian cell lines is dependent upon source of apoE and can be monitored in living cells. Neuroscience Letters. 341(1). 69–73. 2 indexed citations

16.

Nauck, Markus, Bernhard R. Winkelmann, Michael M. Hoffmann, et al.. (2002). C(−260)T polymorphism in the promoter of the CD14 gene is not associated with coronary artery disease and myocardial infarction in the Ludwigshafen Risk and Cardiovascular Health (LURIC) study. The American Journal of Cardiology. 90(11). 1249–1252. 20 indexed citations

17.

Hoffmann, Michael M., Hubert Scharnagl, W. Köster, et al.. (2001). Apolipoprotein E1 Baden (Arg180→Cys). Clinica Chimica Acta. 303(1-2). 41–48. 16 indexed citations

18.

Huber, G., Winfried März, Joel R. Martin, et al.. (2000). Characterization of transgenic mice expressing Apolipoprotein E4(C112R) and Apolipoprotein E4(L28P; C112R). Neuroscience. 101(1). 211–218. 13 indexed citations

19.

Winkler, Karl, Hubert Scharnagl, U Tisljar, et al.. (1999). Competition of Aβ amyloid peptide and apolipoprotein E for receptor-mediated endocytosis. Journal of Lipid Research. 40(3). 447–455. 50 indexed citations

20.

März, Winfried, Michael M. Hoffmann, Hubert Scharnagl, et al.. (1998). Apolipoprotein E2 (Arg136 → Cys) mutation in the receptor binding domain of apoE is not associated with dominant type III hyperlipoproteinemia. Journal of Lipid Research. 39(3). 658–669. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact